Product
Losartan
Aliases
losartan potassium, Losartan potassium
Name
Losartan potassium Tablets, 25 mg
INN Name
losartan potassium
FDA Approved
Yes
14 clinical trials
1 organization
15 indications
1 document
Indication
HypertensionIndication
Aortic StenosisIndication
Aortic RegurgitationIndication
LeishmaniasisIndication
Left Ventricular HypertrophyIndication
Radiation-Induced FibrosisIndication
Knee ArthroplastyIndication
TotalIndication
Membranous NephropathyIndication
Congestive Heart FailureIndication
ChemotherapyIndication
Colorectal CancerIndication
MucositisIndication
Oral MucositisIndication
Diabetes MellitusClinical trial
Antihypertensive Effect of Different Doses of ROSTAFUROXIN in Comparison With Losartan, Assessed by Office and Ambulatory Blood Pressure Monitoring in a Hypertensive Population Selected According to a Specific Genetic Profile.Status: Completed, Estimated PCD: 2018-02-08
Clinical trial
A Prospective, Multicentre, Randomized, Open Label, Evaluator-Blind, Phase IV Study to Evaluate the Effect on Improvement of Left Ventricular Hypertrophy by the Control of Blood Pressure in Hypertension Patients With Aortic Valve DiseaseStatus: Completed, Estimated PCD: 2022-07-25
Clinical trial
A Phase III, Randomized, Active-comparator Controlled Clinical Trial to Study the Efficacy and Safety of MK-0954A in Japanese Patients With Essential Hypertension Uncontrolled With the High Dose of Losartan PotassiumStatus: Completed, Estimated PCD: 2012-02-07
Clinical trial
A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer PatientsStatus: Recruiting, Estimated PCD: 2027-08-17
Clinical trial
A Phase III, Randomized, Open-Label, Parallel-Group, Dose-Ranging Clinical Trial to Study the Safety and Efficacy of MK954/Losartan Potassium in Pediatric Patients With HypertensionStatus: Completed, Estimated PCD: 2012-08-14
Clinical trial
Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using LosartanStatus: Recruiting, Estimated PCD: 2027-06-30
Clinical trial
Efficacy and Safety Evaluation of QingReMoShen Granule in the Treatment of Idiopathic Membranous Nephropathy : A Randomized Double-Blind Controlled Clinical StudyStatus: Completed, Estimated PCD: 2016-02-01
Clinical trial
A Multi-center, Double-Blind, Randomized, Parallel Group Study to Evaluate the Effects of Two Different Doses of Losartan on Morbidity and Mortality in Patients With Symptomatic Heart Failure Intolerant of ACE Inhibitor TreatmentStatus: Completed, Estimated PCD: 2009-03-31
Clinical trial
Randomized Open-label Trial to Evaluate the Effectiveness of Diet Management With a Losartan Titration Regimen Versus Losartan Titration Regimen Alone on Blood Pressure Reduction in Hypertensives.Status: Completed, Estimated PCD: 2009-07-01
Clinical trial
Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer PatientsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Prevention of Hypertension Incidence and Diabetes Italian Assessment Study. Therapeutic Strategies of Prevention of Diabetes and Hypertension in Subjects With Metabolic Syndrome and High-Normal Blood Pressure.Status: Terminated, Estimated PCD: 2010-03-01
Clinical trial
A Randomized, Double-Blind, Active Comparator Study to Evaluate the Antihypertensive Efficacy and Safety of Losartan/HCTZ Combination as Compared to Losartan Monotherapy in Pediatric Patients With Essential HypertensionStatus: Terminated, Estimated PCD: 2007-10-22
Clinical trial
A Randomized, Open-label, Comparative, Non-inferiority, Multicenter Study to Compare Efficacy of Losartan Potassium Group and Carvedilol Group on Arterial Stiffness in Essential Hypertension PatientsStatus: Completed, Estimated PCD: 2009-09-01
Organization
Jubilant Cadista Pharmaceuticals Inc.